Evidence map›Paper›PMID 40348883›Full record

ArticleScientific reports2025

Synthesis and application of Cobalt-Silver nanohybrid for antimicrobial wastewater treatment and agricultural productivity enhancement.

Sayed M S Abo El-Souad, Marwa A Ramadan, D Zahran

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sayed M S Abo El-SouadDepartment of Botany and Microbiology, Faculty of Science, Cairo University, Giza, 12613, Egypt. msayed@sci.cu.edu.eg.
Marwa A RamadanDepartment of laser application in metrology, photochemistry and agriculture, National Institute of Laser Enhanced Science (NILES) Cairo University, Giza, 12613, Egypt.
D ZahranDepartment of Botany and Microbiology, Faculty of Science, Cairo University, Giza, 12613, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1- This work emphasises the potential of Co@Ag-NPs as an efficient antimicrobial agent. The scientific community has recently shown silver nanohybrids to maintain plural consistency and their potential applications in wastewater treatment. Where these nanohybrids showed highly removing capacity of the three main contaminants (pesticides, microorganisms, and heavy metals) from waste water. The ability of silver and cobalt nanohybrids to inhibit bacteria and fungi that cause illnesses both in vitro and in vivo has made them an outstanding antimicrobial agent. Cobalt-silver nanohybrid particles (Co@AgNPs) have antibacterial properties against both Gram-positive and Gram-negative bacteria, including those that are resistant to multiple drugs. Co@AgNPs have several simultaneous modes of action, and when combined with organic chemicals or medicines that fight bacteria, they have demonstrated a synergistic effect on infections. Because of their unique properties, silver and cobalt nanohybrids can be used in medical and healthcare goods to effectively treat or prevent infections. The preparation and characterization of highly stable cobalt silver nanohybrid (Co@Ag) have been reported. Out of the water samples, four bacterial and seven fungal isolates are identified. Various concentrations of Co@Ag, ranging from 10

Indexed as

AgricultureAnti-Infective AgentsCobaltMetal NanoparticlesSilverWastewaterWater PurificationAnti-Bacterial AgentsBacteriaFungiMicrobial Sensitivity TestsAnti-Bacterial AgentsAnti-Infective AgentsCobaltSilverWastewaterAntibacterialAntifungalMetallic nanocompositeWater treatment and wheat growth enhancement

Identifiers

PMID40348883
PMCPMC12065837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.